Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicenter trial of doxepin hydrochloride buccal film for insomnia disorder
CTR20240056Phase 3Completed
- Sponsor
- Lipin Pharmaceutical
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxepin in Insomnia, sponsored by Lipin Pharmaceutical. Started Jan 2024; status: completed.
02
Drugs
doxepin
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20240056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240056.